Fabior Topical Foam 0.1pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Fabior: Topical foam (0.1%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

TAZAROTENE (ta ZAR oh teen) is applied to the skin to treat acne.

In-Depth Information

Fabior 0.1% Topical Foam

NDC: 001450020
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Acne Vulgaris

Storage Information
Flammable, keep away from heat and flame
Store upright
Do Not Store at Temperatures Above 120 degrees F (49 degrees C)
Protect from freezing
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Fabior 0.1% Topical Foam

Reported Side Effects for Fabior 0.1% Topical Foam

Allergic Skin Reaction Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
<30.0%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Skin Discoloration Incidence:
<10.0%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Dry Skin Incidence:
1.0-30.0%*
Severity: MILD
Onset: DELAYED
Bleeding Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Skin Irritation Incidence:
1.0-30.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
6.0-34.0%*
Severity: MODERATE
Onset: EARLY
Photosensitivity Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Fabior

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5